Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Salt Lake City
- Most recent report
- 8-K, filed Aug 4, 2026
- Incorporated
- Delaware
- Filings on record
- 812 filings
- On EDGAR
- CIK 1535955
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 63
News 8 of 420
Prospectuses and Registrations 8 of 60
- S-8 Registration statement for an employee plan Jun 9, 2026
- 424B5 Prospectus supplement for an offering Feb 26, 2026
- 424B5 Prospectus supplement for an offering Apr 26, 2024
- S-3/A Shelf registration statement, amended Apr 23, 2024
- S-3 Shelf registration statement Nov 22, 2023
- 424B5 Prospectus supplement for an offering Apr 3, 2023
- 424B5 Prospectus supplement for an offering Jan 27, 2021
- 424B5 Prospectus supplement for an offering Jan 25, 2021
Proxies 8 of 26
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2025
- PRE 14A Preliminary proxy statement Apr 10, 2025
- DEFA14A Extra proxy material Jun 3, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 27, 2023
- PRE 14A Preliminary proxy statement Mar 17, 2023
Ownership 8 of 209
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Aug 7, 2026
- 3 Insider reported their initial holding Aug 7, 2026
- 4 Insider reported a trade Jun 30, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- SCHEDULE 13G Large holder reported a passive stake May 15, 2026
Other 8 of 34
- EFFECT Notice that a registration became effective Apr 25, 2024
- CORRESP Reply to SEC staff Apr 24, 2024
- UPLOAD Comment letter from SEC staff Nov 29, 2023
- ARS Annual report sent to shareholders Mar 20, 2023
- 8-A12G Mar 10, 2023
- EFFECT Notice that a registration became effective Nov 23, 2020
- CORRESP Reply to SEC staff Nov 20, 2020
- UPLOAD Comment letter from SEC staff Nov 20, 2020
Everything here comes from Lipocine Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.